Health Care [ 5/12 ] | Pharmaceuticals [ 34/74 ]
NASDAQ | Common Stock
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of therapies for neurology and oncology diseases in the United States.
It develops TPI 287, an investigational chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma, metastatic breast cancer with brain metastases, non-small cell lung cancer, castration-resistant prostate cancer, and neuroblastoma; and Berubicin, an investigational anthracycline chemotherapy agent, which is in Phase II clinical trial for the treatment of glioblastoma and brain tumors.
The company was incorporated in 2017 and is headquartered in Houston, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Dec 31, 25 | -10.15 Increased by +72.81% | -5.09 Decreased by -99.41% |
| Nov 14, 25 | -5.76 Decreased by -2.18 K% | -0.63 Decreased by -814.29% |
| Aug 13, 25 | -6.42 Increased by +4.45% | -9.60 Increased by +33.13% |
| Apr 30, 25 | -2.25 Decreased by -452.38% | -2.00 Decreased by -12.36% |
| Mar 31, 25 | -37.33 Increased by +99.87% | -7.33 Decreased by -409.28% |
| Nov 13, 24 | -0.25 Increased by +90.64% | -0.10 Decreased by -152.70% |
| Aug 14, 24 | -6.72 Decreased by -547.88% | - |
| May 15, 24 | -0.41 Increased by +84.27% | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 0.00 Decreased by -100.00% | -5.96 M Decreased by -87.50% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 25 | 0.00 Decreased by N/A% | -3.22 M Increased by +42.59% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 Decreased by N/A% | -2.37 M Increased by +6.16% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 3.14 K Decreased by -50.64% | -4.30 M Decreased by -21.34% | Decreased by -136.98 K% Decreased by -145.86% |
| Dec 31, 24 | 3.14 K Increased by +N/A% | -3.18 M Increased by +40.91% | Decreased by -101.16 K% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by N/A% | -5.61 M Decreased by -23.95% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 0.00 Decreased by N/A% | -2.53 M Increased by +37.07% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 24 | 6.36 K Increased by +N/A% | -3.54 M Increased by +28.13% | Decreased by -55.72 K% Decreased by N/A% |